Evidence for genetic heterogeneity between clinical subtypes of bipolar disorder

A. W. Charney, D. M. Ruderfer, E. A. Stahl, J. L. Moran, K. Chambert, R. A. Belliveau, L. Forty, K. Gordon-Smith, A. Di Florio, P. H. Lee, E. J. Bromet, Peter F Buckley, M. A. Escamilla, A. H. Fanous, L. J. Fochtmann, D. S. Lehrer, D. Malaspina, S. R. Marder, C. P. Morley, H. Nicolini & 25 others D. O. Perkins, J. J. Rakofsky, M. H. Rapaport, H. Medeiros, J. L. Sobell, E. K. Green, L. Backlund, S. E. Bergen, A. Juréus, M. Schalling, P. Lichtenstein, P. Roussos, J. A. Knowles, I. Jones, L. A. Jones, C. M. Hultman, R. H. Perlis, S. M. Purcell, S. A. McCarroll, C. N. Pato, M. T. Pato, N. Craddock, M. Landén, J. W. Smoller, P. Sklar

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

We performed a genome-wide association study of 6447 bipolar disorder (BD) cases and 12 639 controls from the International Cohort Collection for Bipolar Disorder (ICCBD). Meta-analysis was performed with prior results from the Psychiatric Genomics Consortium Bipolar Disorder Working Group for a combined sample of 13 902 cases and 19 279 controls. We identified eight genome-wide significant, associated regions, including a novel associated region on chromosome 10 (rs10884920; P = 3.28 × 10-8) that includes the brain-enriched cytoskeleton protein adducin 3 (ADD3), a non-coding RNA, and a neuropeptide-specific aminopeptidase P (XPNPEP1). Our large sample size allowed us to test the heritability and genetic correlation of BD subtypes and investigate their genetic overlap with schizophrenia and major depressive disorder. We found a significant difference in heritability of the two most common forms of BD (BD I SNP-h2 = 0.35; BD II SNP-h2 = 0.25; P = 0.02). The genetic correlation between BD I and BD II was 0.78, whereas the genetic correlation was 0.97 when BD cohorts containing both types were compared. In addition, we demonstrated a significantly greater load of polygenic risk alleles for schizophrenia and BD in patients with BD I compared with patients with BD II, and a greater load of schizophrenia risk alleles in patients with the bipolar type of schizoaffective disorder compared with patients with either BD I or BD II. These results point to a partial difference in the genetic architecture of BD subtypes as currently defined.

Original languageEnglish (US)
Article numbere993
JournalTranslational Psychiatry
Volume7
Issue number1
DOIs
StatePublished - Jan 1 2017

Fingerprint

Genetic Heterogeneity
Bipolar Disorder
Schizophrenia
Single Nucleotide Polymorphism
Alleles
Chromosomes, Human, Pair 10
Untranslated RNA
Genome-Wide Association Study
Major Depressive Disorder
Genomics
Neuropeptides
Cytoskeleton

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Cellular and Molecular Neuroscience
  • Biological Psychiatry

Cite this

Charney, A. W., Ruderfer, D. M., Stahl, E. A., Moran, J. L., Chambert, K., Belliveau, R. A., ... Sklar, P. (2017). Evidence for genetic heterogeneity between clinical subtypes of bipolar disorder. Translational Psychiatry, 7(1), [e993]. https://doi.org/10.1038/tp.2016.242

Evidence for genetic heterogeneity between clinical subtypes of bipolar disorder. / Charney, A. W.; Ruderfer, D. M.; Stahl, E. A.; Moran, J. L.; Chambert, K.; Belliveau, R. A.; Forty, L.; Gordon-Smith, K.; Di Florio, A.; Lee, P. H.; Bromet, E. J.; Buckley, Peter F; Escamilla, M. A.; Fanous, A. H.; Fochtmann, L. J.; Lehrer, D. S.; Malaspina, D.; Marder, S. R.; Morley, C. P.; Nicolini, H.; Perkins, D. O.; Rakofsky, J. J.; Rapaport, M. H.; Medeiros, H.; Sobell, J. L.; Green, E. K.; Backlund, L.; Bergen, S. E.; Juréus, A.; Schalling, M.; Lichtenstein, P.; Roussos, P.; Knowles, J. A.; Jones, I.; Jones, L. A.; Hultman, C. M.; Perlis, R. H.; Purcell, S. M.; McCarroll, S. A.; Pato, C. N.; Pato, M. T.; Craddock, N.; Landén, M.; Smoller, J. W.; Sklar, P.

In: Translational Psychiatry, Vol. 7, No. 1, e993, 01.01.2017.

Research output: Contribution to journalArticle

Charney, AW, Ruderfer, DM, Stahl, EA, Moran, JL, Chambert, K, Belliveau, RA, Forty, L, Gordon-Smith, K, Di Florio, A, Lee, PH, Bromet, EJ, Buckley, PF, Escamilla, MA, Fanous, AH, Fochtmann, LJ, Lehrer, DS, Malaspina, D, Marder, SR, Morley, CP, Nicolini, H, Perkins, DO, Rakofsky, JJ, Rapaport, MH, Medeiros, H, Sobell, JL, Green, EK, Backlund, L, Bergen, SE, Juréus, A, Schalling, M, Lichtenstein, P, Roussos, P, Knowles, JA, Jones, I, Jones, LA, Hultman, CM, Perlis, RH, Purcell, SM, McCarroll, SA, Pato, CN, Pato, MT, Craddock, N, Landén, M, Smoller, JW & Sklar, P 2017, 'Evidence for genetic heterogeneity between clinical subtypes of bipolar disorder', Translational Psychiatry, vol. 7, no. 1, e993. https://doi.org/10.1038/tp.2016.242
Charney AW, Ruderfer DM, Stahl EA, Moran JL, Chambert K, Belliveau RA et al. Evidence for genetic heterogeneity between clinical subtypes of bipolar disorder. Translational Psychiatry. 2017 Jan 1;7(1). e993. https://doi.org/10.1038/tp.2016.242
Charney, A. W. ; Ruderfer, D. M. ; Stahl, E. A. ; Moran, J. L. ; Chambert, K. ; Belliveau, R. A. ; Forty, L. ; Gordon-Smith, K. ; Di Florio, A. ; Lee, P. H. ; Bromet, E. J. ; Buckley, Peter F ; Escamilla, M. A. ; Fanous, A. H. ; Fochtmann, L. J. ; Lehrer, D. S. ; Malaspina, D. ; Marder, S. R. ; Morley, C. P. ; Nicolini, H. ; Perkins, D. O. ; Rakofsky, J. J. ; Rapaport, M. H. ; Medeiros, H. ; Sobell, J. L. ; Green, E. K. ; Backlund, L. ; Bergen, S. E. ; Juréus, A. ; Schalling, M. ; Lichtenstein, P. ; Roussos, P. ; Knowles, J. A. ; Jones, I. ; Jones, L. A. ; Hultman, C. M. ; Perlis, R. H. ; Purcell, S. M. ; McCarroll, S. A. ; Pato, C. N. ; Pato, M. T. ; Craddock, N. ; Landén, M. ; Smoller, J. W. ; Sklar, P. / Evidence for genetic heterogeneity between clinical subtypes of bipolar disorder. In: Translational Psychiatry. 2017 ; Vol. 7, No. 1.
@article{7669c285d18f400ba9ebb9b6cc212b67,
title = "Evidence for genetic heterogeneity between clinical subtypes of bipolar disorder",
abstract = "We performed a genome-wide association study of 6447 bipolar disorder (BD) cases and 12 639 controls from the International Cohort Collection for Bipolar Disorder (ICCBD). Meta-analysis was performed with prior results from the Psychiatric Genomics Consortium Bipolar Disorder Working Group for a combined sample of 13 902 cases and 19 279 controls. We identified eight genome-wide significant, associated regions, including a novel associated region on chromosome 10 (rs10884920; P = 3.28 × 10-8) that includes the brain-enriched cytoskeleton protein adducin 3 (ADD3), a non-coding RNA, and a neuropeptide-specific aminopeptidase P (XPNPEP1). Our large sample size allowed us to test the heritability and genetic correlation of BD subtypes and investigate their genetic overlap with schizophrenia and major depressive disorder. We found a significant difference in heritability of the two most common forms of BD (BD I SNP-h2 = 0.35; BD II SNP-h2 = 0.25; P = 0.02). The genetic correlation between BD I and BD II was 0.78, whereas the genetic correlation was 0.97 when BD cohorts containing both types were compared. In addition, we demonstrated a significantly greater load of polygenic risk alleles for schizophrenia and BD in patients with BD I compared with patients with BD II, and a greater load of schizophrenia risk alleles in patients with the bipolar type of schizoaffective disorder compared with patients with either BD I or BD II. These results point to a partial difference in the genetic architecture of BD subtypes as currently defined.",
author = "Charney, {A. W.} and Ruderfer, {D. M.} and Stahl, {E. A.} and Moran, {J. L.} and K. Chambert and Belliveau, {R. A.} and L. Forty and K. Gordon-Smith and {Di Florio}, A. and Lee, {P. H.} and Bromet, {E. J.} and Buckley, {Peter F} and Escamilla, {M. A.} and Fanous, {A. H.} and Fochtmann, {L. J.} and Lehrer, {D. S.} and D. Malaspina and Marder, {S. R.} and Morley, {C. P.} and H. Nicolini and Perkins, {D. O.} and Rakofsky, {J. J.} and Rapaport, {M. H.} and H. Medeiros and Sobell, {J. L.} and Green, {E. K.} and L. Backlund and Bergen, {S. E.} and A. Jur{\'e}us and M. Schalling and P. Lichtenstein and P. Roussos and Knowles, {J. A.} and I. Jones and Jones, {L. A.} and Hultman, {C. M.} and Perlis, {R. H.} and Purcell, {S. M.} and McCarroll, {S. A.} and Pato, {C. N.} and Pato, {M. T.} and N. Craddock and M. Land{\'e}n and Smoller, {J. W.} and P. Sklar",
year = "2017",
month = "1",
day = "1",
doi = "10.1038/tp.2016.242",
language = "English (US)",
volume = "7",
journal = "Translational Psychiatry",
issn = "2158-3188",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Evidence for genetic heterogeneity between clinical subtypes of bipolar disorder

AU - Charney, A. W.

AU - Ruderfer, D. M.

AU - Stahl, E. A.

AU - Moran, J. L.

AU - Chambert, K.

AU - Belliveau, R. A.

AU - Forty, L.

AU - Gordon-Smith, K.

AU - Di Florio, A.

AU - Lee, P. H.

AU - Bromet, E. J.

AU - Buckley, Peter F

AU - Escamilla, M. A.

AU - Fanous, A. H.

AU - Fochtmann, L. J.

AU - Lehrer, D. S.

AU - Malaspina, D.

AU - Marder, S. R.

AU - Morley, C. P.

AU - Nicolini, H.

AU - Perkins, D. O.

AU - Rakofsky, J. J.

AU - Rapaport, M. H.

AU - Medeiros, H.

AU - Sobell, J. L.

AU - Green, E. K.

AU - Backlund, L.

AU - Bergen, S. E.

AU - Juréus, A.

AU - Schalling, M.

AU - Lichtenstein, P.

AU - Roussos, P.

AU - Knowles, J. A.

AU - Jones, I.

AU - Jones, L. A.

AU - Hultman, C. M.

AU - Perlis, R. H.

AU - Purcell, S. M.

AU - McCarroll, S. A.

AU - Pato, C. N.

AU - Pato, M. T.

AU - Craddock, N.

AU - Landén, M.

AU - Smoller, J. W.

AU - Sklar, P.

PY - 2017/1/1

Y1 - 2017/1/1

N2 - We performed a genome-wide association study of 6447 bipolar disorder (BD) cases and 12 639 controls from the International Cohort Collection for Bipolar Disorder (ICCBD). Meta-analysis was performed with prior results from the Psychiatric Genomics Consortium Bipolar Disorder Working Group for a combined sample of 13 902 cases and 19 279 controls. We identified eight genome-wide significant, associated regions, including a novel associated region on chromosome 10 (rs10884920; P = 3.28 × 10-8) that includes the brain-enriched cytoskeleton protein adducin 3 (ADD3), a non-coding RNA, and a neuropeptide-specific aminopeptidase P (XPNPEP1). Our large sample size allowed us to test the heritability and genetic correlation of BD subtypes and investigate their genetic overlap with schizophrenia and major depressive disorder. We found a significant difference in heritability of the two most common forms of BD (BD I SNP-h2 = 0.35; BD II SNP-h2 = 0.25; P = 0.02). The genetic correlation between BD I and BD II was 0.78, whereas the genetic correlation was 0.97 when BD cohorts containing both types were compared. In addition, we demonstrated a significantly greater load of polygenic risk alleles for schizophrenia and BD in patients with BD I compared with patients with BD II, and a greater load of schizophrenia risk alleles in patients with the bipolar type of schizoaffective disorder compared with patients with either BD I or BD II. These results point to a partial difference in the genetic architecture of BD subtypes as currently defined.

AB - We performed a genome-wide association study of 6447 bipolar disorder (BD) cases and 12 639 controls from the International Cohort Collection for Bipolar Disorder (ICCBD). Meta-analysis was performed with prior results from the Psychiatric Genomics Consortium Bipolar Disorder Working Group for a combined sample of 13 902 cases and 19 279 controls. We identified eight genome-wide significant, associated regions, including a novel associated region on chromosome 10 (rs10884920; P = 3.28 × 10-8) that includes the brain-enriched cytoskeleton protein adducin 3 (ADD3), a non-coding RNA, and a neuropeptide-specific aminopeptidase P (XPNPEP1). Our large sample size allowed us to test the heritability and genetic correlation of BD subtypes and investigate their genetic overlap with schizophrenia and major depressive disorder. We found a significant difference in heritability of the two most common forms of BD (BD I SNP-h2 = 0.35; BD II SNP-h2 = 0.25; P = 0.02). The genetic correlation between BD I and BD II was 0.78, whereas the genetic correlation was 0.97 when BD cohorts containing both types were compared. In addition, we demonstrated a significantly greater load of polygenic risk alleles for schizophrenia and BD in patients with BD I compared with patients with BD II, and a greater load of schizophrenia risk alleles in patients with the bipolar type of schizoaffective disorder compared with patients with either BD I or BD II. These results point to a partial difference in the genetic architecture of BD subtypes as currently defined.

UR - http://www.scopus.com/inward/record.url?scp=85020912677&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85020912677&partnerID=8YFLogxK

U2 - 10.1038/tp.2016.242

DO - 10.1038/tp.2016.242

M3 - Article

VL - 7

JO - Translational Psychiatry

JF - Translational Psychiatry

SN - 2158-3188

IS - 1

M1 - e993

ER -